Navigation Links
Oncology Metrics and Cureline Announce Joint Marketing Agreement
Date:1/9/2008

Access to high quality, fully annotated serum, tissue and blood samples are

available for Genomic and Proteomic Research

DALLAS-FORT WORTH, Texas, Jan. 9 /PRNewswire/ -- Oncology Metrics, a business that develops products and services to help accelerate advancements in the treatment of cancer, and Cureline Inc., a global biosample management company dedicated to innovation in human tissue research, have reached an agreement to collaborate on oncology biospecimen procurement and management. The goal of this collaboration is to facilitate the collection and preservation of high quality pre-treatment and post-treatment samples with maximum efficiency.

Human specimens are used extensively in drug discovery and development for characterization of mutations and expression profiles that define severe diseases such as cancer, asthma, rheumatoid arthritis, diabetes and other conditions, and that could be used for developing personalized therapeutics, vaccines and diagnostics. One of the limiting steps in the research and development process is getting access to well-preserved clinically defined samples from patients with detailed and accurate health records. The collaboration between Oncology Metrics' sample procurement network Cure Pace and Cureline will improve the access of industrial and academic researchers to high quality biospecimens.

Olga Potapova, Ph.D., Founder and CEO of Cureline, views the collaboration as "a unique opportunity to provide to academia and the industry cancer biospecimens collected from diverse ethnic background populations through Cureline's clinical network in Eastern Europe and Asia and through the Oncology Metrics' clinical network in the USA."

Commenting on the collaboration, Warren Dodge, President and CEO of Oncology Metrics said "by leveraging the scientific expertise and access to tissue and our domestic access to serum and fresh whole blood, we become a much better resource for the scientis
'/>"/>

SOURCE Oncology Metrics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
2. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
3. AG Mednet to Provide Image Network for Southwest Oncology Group
4. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
5. PRA International to Present Audioconference on Oncology Research - Nov. 8
6. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
7. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
10. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
11. VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , TUSTIN, Calif., Dec. 2 /PRNewswire-F...aq: PPHM ) today reported completion of patient e...al of Cotara® in patients with relapsed gliob...ain cancer. Cotara is a targeted monoclonal antib...potential new treatment for GBM. Cotara specifica...
(Date:12/2/2009)..., , LELYSTAD, The Netherlands, Decembe...lands based biotechnology company focusing on prot...une therapeutics today announced that it,has appoi...ficer. , Dr. Mol will be responsible for ...l management and strategic direction of the compan...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...on its novel oral JAK2 inhibitor, SB1518, at The A...and Exposition in New Orleans. ,, Data will be ... dose-escalation trial of SB1518 detailing its saf...mic (PK/PD) profile in dose levels ranging from 10...
(Date:12/2/2009)..., , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCa...AEZ) (the "Company"), a global biopharmaceutical c...today announced that the U.S. Food and Drug Admini...for the Company,s PI3K/Akt pathway inhibitor compo...elapsed/refractory multiple myeloma. Keryx Biophar...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... (Nasdaq:,EVVV), a global endovascular device comp...al first quarter of 2008 and its revised financial...s net sales were $101.3 million in the,first quart...me quarter of,the prior year and a 10% increase ov... sales over the same quarter of the prior year was...
...rporation,(Nasdaq: MASI ), the inventor of Pulse,...rfusion pulse oximetry,today announced that it is ...ual Health Care Conference at the InterContinental...:30 a.m. ET. Joe E. Kiani, Chairman will be,presen...e available on the Masimo Web,site at http://www....
...E genetics,(Nasdaq: DCGN ) today announced its co... March 31, 2008. A conference call to discuss the ...will be webcast live tomorrow,Friday, May 2, at 8:...ime,(details below)., Net loss for the quarter en...$22.6 million for the first quarter 2007. Basic an...
Other Biology Technology:ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 2ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 3ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 4ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 5ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 6ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 7ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 8ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 9ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 10ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 11ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance 12Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference 2deCODE genetics Announces First Quarter 2008 Financial Results 2deCODE genetics Announces First Quarter 2008 Financial Results 3deCODE genetics Announces First Quarter 2008 Financial Results 4deCODE genetics Announces First Quarter 2008 Financial Results 5deCODE genetics Announces First Quarter 2008 Financial Results 6deCODE genetics Announces First Quarter 2008 Financial Results 7deCODE genetics Announces First Quarter 2008 Financial Results 8deCODE genetics Announces First Quarter 2008 Financial Results 9
(Date:12/3/2009)...learn new information and adapt to changes in our ...emories, appears to lie in the minute junctions wh...udy by NYU Langone Medicine Center researchers. Th...al Nature . , The scientists, led by Wen-Biao ...uroscience at NYU School of Medicine, discovered t...
(Date:12/3/2009)...ndows or solar panels that repels grime and dirt? ...lectric car? New Tel Aviv University research, jus...breakthrough in assembling peptides at the nano-sc... come true in just a few years. , Operating in t...of a meter) and even smaller, graduate student Lih...
(Date:12/3/2009)... in its 32nd year, the CTRC-AACR San Antonio Breas...n breast cancer science and world leaders from ind...east cancer. , This year, more than 8,500 scien...enry B. Gonzales Convention Center in San Antonio ...ip between the American Association for Cancer Res...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2A window that washes itself? 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Iterative reconstruction technique significantly reduces patient radiation dose during CT scans 54816 1Kinetic variable most useful for identifying malignant MRI detected breast lesions identified 54814 1Nanomagnets guide stem cells to damaged tissue 13621 1
...ansas Flint Hills and access to the Konza Prairie ...chers certainly know grasslands. They,re using tha...swana and South Africa on studies of African grass...nza and other grass-dominated ecosystems around th...ity distinguished professor of biology. , The res...
...uncomfortable condition that affects millions of p...ave identified some of the genes that are causing ...io Videman, in the Faculty of Rehabilitation Medic... related to disc degeneration. , "We found more g...scovered in 30 prior studies," said Videman. "This...
...he first time ever, a North Atlantic right whale t...as administered a sedation mixture that made it po...tanglement. , The rescue involved the efforts of...le Oceanographic Institution (WHOI), NOAA Fisherie...glement Network based at the Provincetown (MA) Cen...
Other Biology News:K-State biologist collaborating with researchers in Africa on grassland sustainability, biodiversity 2Genes identified that are linked to spinal disc degeneration 2Right whale sedation enables disentanglement effort 2Right whale sedation enables disentanglement effort 3Right whale sedation enables disentanglement effort 4
T4 DNA Ligase; (1 x 103 U/ml) or (5 x 103 U/ml) supplied with 10x ligation buffer that includes ATP from Roche Applied Science
...DNA Ligase catalyzes the formation of a phosphodie...hate termini in nicked duplex DNA molecules or bet...omplementary strand at 45 - 65?. Tfi DNA Ligase is...n conventional DNA ligases, Thus, Tfi DNA Ligase i...
Mouse Anti-Mouse MHC Class I H-2Kd, Dd, q, u, v Monoclonal Antibody, Biotin Conjugated, Clone A5A1-Do4 from Meridian Life Science, Inc.
Rabbit Anti-hnRNP U Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: